Rycontuss Liquid
FDA Label NDC 65852-021

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Dextrum Laboratories, Inc for the product Rycontuss (NDC 65852-021). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient section, inactive ingredient section, ask a doctor section, do not use section, keep out of reach of children section., pregnancy or breast feeding section, purpose section, question section, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.